Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Parkinson's disease, proteins, and prions: milestones.

Movement disorders : official journal of the Movement Disorder Society - 1 May 2011

Olanow C Warren, McNaught K

Abstract excerpt

Parkinson's disease (PD) is characterized by protein accumulation in the form of Lewy bodies and neurites. It is thus reasonable to consider that alterations in protein handling in the form of increased production, impaired clearance, or both might be central to the etiopathogenesis of the disease. Increasing genetic, laboratory and pathologic evidence has accumulated over the past 25 years supporting this...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autophagy
Share to History, 20th Century
Share to History, 21st Century

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lewy Bodies

Share to Parkinson Disease

Share to Prion Diseases

Share to Prions

Share to Ubiquitin

Source

Identifiers

PMID: 21626551
DOI: 10.1002/mds.23767

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Parkinson's disease, proteins, and prions: milestones.PMID 21626551Read ↗

A critical review of the development and importance of proteinaceous aggregates in animal models of Parkinson's disease: new insights into Lewy body formationSemantic proximity Read ↗

Parkinson disease: from pathology to molecular disease mechanisms.Semantic proximity Read ↗

Etiology and pathogenesis of Parkinson's diseaseSemantic proximity Read ↗

Disruption of protein quality control in Parkinson's disease.Semantic proximity Read ↗

Current concepts and controversies in the pathogenesis of Parkinson’s disease dementia and Dementia with Lewy BodiesSemantic proximity Read ↗

All Roads Lead to Rome: Different Molecular Players Converge to Common Toxic Pathways in NeurodegenerationSemantic proximity Read ↗

Parkinson’s Disease-Related Genes and Lipid AlterationSemantic proximity Read ↗

⍺-Synuclein levels in Parkinson's disease – Cell types and forms that contribute to pathogenesisSemantic proximity Read ↗

Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?Semantic proximity Read ↗

Mitochondrial Dysfunction, Protein Misfolding and Neuroinflammation in Parkinson’s Disease: Roads to Biomarker DiscoverySemantic proximity Read ↗

Impaired intracellular trafficking defines early Parkinson's diseaseSemantic proximity Read ↗

Protein Misfolding and Aggregation in Parkinson's DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.